BioXcell功能性抗體系列推薦-InVivoMAb anti-mouse CD8α
產(chǎn)品信息：
|
- 純度： >95%
- 內(nèi)毒素：<2EU/mg
- 貨號：BE0061
- Clone: 2.43
|
 |
應(yīng)用類型：
in vivo CD8+ T cell depletion
Western blot
參考文獻(xiàn)：
1、"Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses" PLoS One 13(6): e0197702.
2、"Co-inhibitory Molecule B7 Superfamily Member 1 Expressed by Tumor-Infiltrating Myeloid Cells Induces Dysfunction of Anti-tumor CD8(+) T Cells" Immunity 48(4): 773-786 e775.
3、"Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses" Nat Med. doi : 10.1038/nm.4200.
4、"VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors" J Exp Med 212(2): 139-148.
5、"TGFbeta Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity" Cancer Res 75(11): 2232-2242.
6、"Suppression of Fcgamma-receptor-mediated antibody effector function during persistent viral infection" Immunity 42(2): 379-390.
7、"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer" Nature 520(7547): 373-377.
8、"IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis" Nature 522(7556): 345-348.
9、"Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies" Cancer Immunol Res 3(6): 689-701.
10、"Intratumoral administration of mRNA encoding a fusokine consisting of IFN-beta and the ectodomain of the TGF-beta receptor II potentiates antitumor immunity" Oncotarget 5(20): 10100-10113.
BioXcell功能性抗體（清除、阻斷、中和）現(xiàn)貨團(tuán)購中，>50mg大包裝爆款現(xiàn)貨！歡迎選購：https://www.univ-bio.com/sales-once-detail.html?id=1056
Copyright(C) 1998-2026 生物器材網(wǎng) 電話：021-64166852;13621656896 E-mail：info@bio-equip.com